Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
तुलना करने के लिए मीट्रिक्स | MBXBF | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधMBXBFपीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | 25.6x | −3.2x | −0.5x | |
PEG अनुपात | −0.54 | 0.00 | 0.00 | |
क़ीमत/बुक | 1.7x | −1.4x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 2.1x | 1.8x | 2.9x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 191.1% | 57.1% | |
उचित मूल्य अपसाइड | अनलॉक करें | 12.3% | 9.0% | अनलॉक करें |